AAAAAA

   
Results: 1-11 |
Results: 11
Single-dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using I-131-labeled multivalent CC49 single-chain Fvs(1)
Authors: Goel, A Augustine, S Baranowska-Kortylewicz, J Colcher, D Booth, BJM Pavlinkova, G Tempero, M Batra, SK
Citation: A. Goel et al., Single-dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using I-131-labeled multivalent CC49 single-chain Fvs(1), CLIN CANC R, 7(1), 2001, pp. 175-184
Tc-99m-labeled divalent and tetravalent CC49 single-chain Fv's: Novel imaging agents for rapid in vivo localization of human colon carcinoma
Authors: Goel, A Baranowska-Kortylewicz, J Hinrichs, SH Wisecarver, J Pavlinkova, G Augustine, S Colcher, D Booth, BJM Batra, SK
Citation: A. Goel et al., Tc-99m-labeled divalent and tetravalent CC49 single-chain Fv's: Novel imaging agents for rapid in vivo localization of human colon carcinoma, J NUCL MED, 42(10), 2001, pp. 1519-1527
Growth, morphology, and microindentation analysis of Bi2Se3, Bi1.8In0.2Se3, and Bi2Se2.8Te0.2 single crystals
Authors: Augustine, S Mathai, E
Citation: S. Augustine et E. Mathai, Growth, morphology, and microindentation analysis of Bi2Se3, Bi1.8In0.2Se3, and Bi2Se2.8Te0.2 single crystals, MATER RES B, 36(13-14), 2001, pp. 2251-2261
High-dose therapy with (90)yttrium-labeled monoclonal antibody CC49: A phase I trial
Authors: Tempero, M Leichner, P Baranowska-Kortylewicz, J Harrison, K Augustine, S Schlom, J Anderson, J Wisecarver, J Colcher, D
Citation: M. Tempero et al., High-dose therapy with (90)yttrium-labeled monoclonal antibody CC49: A phase I trial, CLIN CANC R, 6(8), 2000, pp. 3095-3102
Phase I/II trial of multiple dose (131)iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma
Authors: Vose, JM Colcher, D Gobar, L Bierman, PJ Augustine, S Tempero, M Leichner, P Lynch, JC Goldenberg, D Armitage, JO
Citation: Jm. Vose et al., Phase I/II trial of multiple dose (131)iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma, LEUK LYMPH, 38(1-2), 2000, pp. 91-101
Morphology and mechanical and viscoelastic properties of natural rubber and styrene butadiene rubber latex blends
Authors: Varkey, JT Augustine, S Groeninckx, G Bhagawan, SS Rao, SS Thomas, S
Citation: Jt. Varkey et al., Morphology and mechanical and viscoelastic properties of natural rubber and styrene butadiene rubber latex blends, J POL SC PP, 38(16), 2000, pp. 2189-2211
Thermal degradation of natural rubber/styrene butadiene rubber latex blends by thermogravimetric method
Authors: Varkey, JT Augustine, S Thomas, S
Citation: Jt. Varkey et al., Thermal degradation of natural rubber/styrene butadiene rubber latex blends by thermogravimetric method, POLYM-PLAST, 39(3), 2000, pp. 415-435
Assessing landscape condition relative to water resources ly the western United States: A strategic approach
Authors: Jones, KB Heggem, DT Wade, TG Neale, AC Ebert, DW Nash, MS Mehaffey, MH Hermann, KA Selle, AR Augustine, S Goodman, IA Pedersen, J Bolgrien, D Viger, JM Chiang, D Lin, CJ Zhong, YH Baker, J Van Remortel, RD
Citation: Kb. Jones et al., Assessing landscape condition relative to water resources ly the western United States: A strategic approach, ENV MON ASS, 64(1), 2000, pp. 227-245
All about e-books
Authors: Augustine, S
Citation: S. Augustine, All about e-books, TECHNOL REV, 103(5), 2000, pp. 17-17
Phase II studies of the glycine antagonist GV150526 in acute stroke - The North American experience
Authors: Babikian, V Licata-Gehr, E Joseph, LN Bailey, P Boyle, R MacDougall, A MacLean, G Wheelock, WB Kolyvas, G Banas, T Wissman, MA Heckaman, JD Porter, MA Bhat, MH Later, PE Wissmann, SD Ottinger, CJ Stevens, JC Plant, R Chang, FL Beatty, J Beatty, TW Cohen, SB Vasquez, AB Schmidt, DW Allen, T Bellavance, A Hebert, L Berger, L Filatrault, R Nasredding, Z Trottier, AG Duplessis, M Maison, FG Ninkovic, S Berman, B Yipelkonen, M Miskin, BM Shaivitz, SA Benavente, O Bruce, G Solomen, D Sherman, D Hart, R Kanter-Carolin, M Lalonde, DR Rogers, D Bruce, G Leonard, A Brott, T Spilker, J Broderick, J Kothari, R Panicoli, A Sauerbeck, L Miller, R Clark, WM Deely, SM Fisher, S Lutsep, H Quinn, J Crawford, J Egan, R Nesbit, G Al-Azzaz, A Earley, C Herr, M Michel, H Dike, G Maragakis, N Polydefkis, M Wagner, K Wang, M Rusa, R Jones, C Kerr, D Moo, L Pardo, C Silverman, I Hoffman, J Diebert, E Jinnah, H York, J Hoke, A Vega-Bermudez, F Comi, A Hillis, A Rich, J Ervin, J Bryan, C Allen, AA Kelley, GB Perll, MF Box, MS Robles, LH Zwibelman, JS Hopewell, DK Ryan, ME Wendland, RT Feinberg, W Coull, B Rose-Taylor, D Ahern, G Anderson, LR Keim, S Sherman, S Rose-Taylor, D Haley, EC Morris, A Ahern, K Johnston, K Solenski, N Nathan, B Bleck, T Worrall, B Leszczyszyn, D Hemstreet, M Kiely, J Burns, T Klein, C Cail, W Huff, S Quinn, J Armstrong, R Provencio, J Snider, R Van Gerpen, J Hsu, C Duke, L Banet, G Choi, J Lee, JM Lowenkopf, T Innes, G Metcalf, C Huang, P Rumball, C Miller, B Haegert, J Holmes, A Oldring, B MacNab, J Grosch, R Deady, B Street, R O'Brien, R Vertesi, L Erhardt, G Finkler, J Tessler, C Glazer, S Noseworthy, R Knazen, M MacDonald, P Smyth, A Karp, J Phillips, B Spiegel, A Bowman, SC Hampsey, JP Habib, MW Schroeder, T Stopnytsky, K Kertecz, A Piotrowski, S Cooper, P Lyden, P Rapp, K Jackson, C Ellis, R Noack, H Sabbagh, M Galasko, D Rapp, K Kelly, N Werner, J Chang, CL Morris, DT Pusek, S Hinn, A Ma, J Bernard, E Phillips, S Reidy, Y Gubitz, G Tanha, F Leckey, R Ansell, J Darvesh, S Aguilar, E Pullicino, P Starr, S Munschauer, FE Ross, DB Norris, D Steinberg, J Zaret, B Maniar, M Sacco, RL Boden-Albala, B Jimenez, M Mohr, JP Kargman, D Marshall, R Elkind, MS Roberts, K Gan, R Shipley, N Aboumatar, S Greene, R Shuaib, A Kadribasic, E Keegan, M Stewart, B Khaan, K Shuaib, A Dean, TR Richardson, P Moussavian, M Faloriji, W Johnson, M Levin, Z Silliman, S Fuqua, PS Berger, A Najjar, S Schwartz, R Solomon, DH Limon, L Hart, RG Sherman, DG Carolin, MCK Lalonde, DR Benavente, O Starkman, S Schubert, GB Dobkin, B Saver, J Vespa, P Alger, J Teitelbaum, J Lachance, N Robillard, A Lachapelle, J Boileau, J Rousseau, S Roy, L Laplante, P Thurston, S McGee, JR Lutz, MA McGee, FE Harris, JK White, RJ O'Bannon, JM Brush, JJ Cohen, RJ Smith, TA Mathe, SA Karner, SF Worthington, AK Deel, JG Tong, D Hock, N Albers, G O'Brien, M Woofenden, A Yenari, M Freyberg, S Guro, G Hock, N Tuhrim, S Augustine, S Weinberger, J Horowitz, D Sheinart, K Schonewille, W Atlas, S Veloso, F Reid, M Adaikari, K Gebhardt, V Nair, CPV Wang, D Vrabel, D McLean, J Kumar, J Garwacki, D Roda, M Hui, E Coyner, J Vrabel, D Honings, D Rose, J Sladana, R Wechsler, L Yasko, L Knepper, L Massaro, L Graham, S Larkin, G Ulicny, T Yonas, H Barch, C Lin, H Brader, E Berkey, K Ludovici, J Kaufmann, A De Cesare, S Hodgdon, A MacLeod, B Thompson, D Piatkowski, S O'Toole, K Yasko, L Ilkhanipour, K Maenza, R Mathias, S Thulborn, K Jungreis, C Cockley, P Corsello, G Ammon, C Rasheed, A Weston, L Bourque, G Silverberg, D Harper, B Robinson, D MacEachern, M Williams, AD Roth, R Rice, M Hogan, J Pellegrino, TR Holland, MT Lanoue, RJ Redding, A Handler, J Haley, EC Alves, WM Elder, L Davenport, K McClure, K Knowlton, S Cuccia, E Maupin, K Lotts, M Hund, M Shelleck, K Szewc, T Cail, W Wagner, G Gates, K Earley, C Haley, EC Johnston, KC Sacco, RL Schuaib, A Snipes, R Wang, DZ Brass, LM Clark, WR Grotta, JC Harrison, M McIntyre, N Zimmerman, H Wellcome, G Snipes, R Watson, D Ordronneau, P Hoke, F Ko, WJ Clayton, L EnneyO' Mara, L Johnson, J Orander, C Card, B Green, S
Citation: V. Babikian et al., Phase II studies of the glycine antagonist GV150526 in acute stroke - The North American experience, STROKE, 31(2), 2000, pp. 358-365
Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: Improved biodistribution and potential for therapeutic application
Authors: Goel, A Colcher, D Baranowska-Kortylewicz, J Augustine, S Booth, BJM Pavlinkova, G Batra, SK
Citation: A. Goel et al., Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: Improved biodistribution and potential for therapeutic application, CANCER RES, 60(24), 2000, pp. 6964-6971
Risultati: 1-11 |